Sugi Predict

Sugi Predict / Compounds / SCHEMBL741049

SCHEMBL741049

SCHEMBL741049

CCOC(=O)n1nc(NC(=O)c2ccc(CCl)cc2)c2cc(C(=O)OC(C)(C)C)sc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE7A Q13946 1/20 0.37
▸ ADORA3 P0DMS8 3/20 0.37
▸ KDM4E B2RXH2 4/20 0.37
▸ ADORA2A P29274 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ MAPT P10636 4/20 0.35
▸ HPGD P15428 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ LMNA P02545 4/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ P2RY14 Q15391 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ TP53 P04637 3/20 0.34
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5980858 0.97 PDE7A (0.35) PDE7AADORA3KDM4EADORA2AADORA1
SCHEMBL742441 0.89 ADORA2A (0.46) PDE7AADORA3KDM4EADORA2AADORA1
SCHEMBL741290 0.89 P2RY14 (0.40) PDE7AKDM4ENPC1MAPTHPGD
SCHEMBL740739 0.88 IKBKE (0.42) MAPTLMNASMN1; SMN2TSHRMAPK1
SCHEMBL741094 0.85 ABL1 (0.48) PDE7AADORA3KDM4EADORA2AADORA1
SCHEMBL739309 0.84 CSNK1D (0.45) PDE7AKDM4ENPC1MAPTHPGD
SCHEMBL741671 0.84 AURKA (0.46) PDE7ANPC1MAPTHPGDMEN1
SCHEMBL742604 0.82 KDM4E (0.46) KDM4EADORA2AADORA1NPC1MAPT
SCHEMBL742599 0.82 KDM4E (0.46) KDM4ENPC1MAPTHPGDALDH1A1
SCHEMBL740459 0.81 FLT3 (0.42) PDE7AKDM4EMAPTHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8481584-B2 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2013-07-09 — — US disclosed
US-20120165311-A1 1H-THIENO[2,3-C]PYRAZOLE DERIVATIVES USEFUL AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-06-28 — — US disclosed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 — — US disclosed
EP-1711177-B1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS PFIZER ITALIA SRL (IT) 2008-05-28 — — EP disclosed
US-20050187209-A1 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2005-08-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165311-A1 1H-THIENO[2,3-C]PYRAZOLE DERIVATIVES USEFUL AS KINASE INHIBITORS MAP3K19, MAP3K1, MAP3K3 PDE7A 639/4885ADORA3 1884/4885KDM4E 1435/4885
US-20050187209-A1 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors MAP3K19, MAP3K1, MAP3K3 PDE7A 648/4885ADORA3 1948/4885KDM4E 1432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.